{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:58:18Z","timestamp":1791194298608,"version":"4.1.0"},"reference-count":29,"publisher":"Frontline Medical Communications, Inc.","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cutaneous Medicine and Surgery"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.sder.2011.11.006","type":"journal-article","created":{"date-parts":[[2012,2,21]],"date-time":"2012-02-21T05:54:42Z","timestamp":1329803682000},"page":"45-49","source":"Crossref","is-referenced-by-count":6,"title":["Malignant Melanoma: Advances in Diagnosis, Prognosis, and Treatment"],"prefix":"10.12788","volume":"31","author":[{"given":"Michael","family":"Krathen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5043","reference":[{"key":"10.1016\/j.sder.2011.11.006_bib1","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.292.22.2771","article-title":"Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria","volume":"292","author":"Abbasi","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.sder.2011.11.006_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2133.1994.tb06881.x","article-title":"An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma","volume":"130","author":"Healsmith","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.11.006_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/archderm.141.4.434","article-title":"First prospective study of the recognition process of melanoma in dermatological practice","volume":"141","author":"Gachon","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.sder.2011.11.006_bib4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaad.2009.09.050","article-title":"Dermatoscopy use by US dermatologists: A cross-sectional survey","volume":"63","author":"Engasser","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.11.006_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2133.2011.10239.x","article-title":"Noninvasive genomic detection of melanoma","volume":"164","author":"Wachsman","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.sder.2011.11.006_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","article-title":"Distinguishing melanocytic nevi from melanoma by DNA copy number changes: Comparative genomic hybridization as a research and diagnostic tool","volume":"19","author":"Bauer","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.sder.2011.11.006_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","article-title":"Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features","volume":"157","author":"Bastian","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.sder.2011.11.006_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00019606-200403000-00004","article-title":"High-resolution array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas","volume":"13","author":"Harvell","year":"2004","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.sder.2011.11.006_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/PAS.0b013e31820393ee","article-title":"Copy number variations and clinical outcome in atypical Spitz tumors","volume":"35","author":"Raskin","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.sder.2011.11.006_bib10","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.sder.2011.11.006_bib11","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.5858\/2009-0653-RAR.1","article-title":"Prognostication in thin cutaneous melanomas","volume":"134","author":"Gimotty","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.sder.2011.11.006_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3322\/canjclin.54.3.131","article-title":"An evidence-based staging system for cutaneous melanoma","volume":"54","author":"Balch","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.sder.2011.11.006_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ncponc1296","article-title":"Melanoma biomarkers: Current status and vision for the future","volume":"6","author":"Larson","year":"2009","journal-title":"Nat Clin Pract Oncol"},{"issue":"Suppl 6","key":"10.1016\/j.sder.2011.11.006_bib15","doi-asserted-by":"crossref","first-page":"vi8","DOI":"10.1093\/annonc\/mdp251","article-title":"Biomarkers in melanoma","volume":"20","author":"Gogas","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.sder.2011.11.006_bib16","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0002-9440(10)62493-5","article-title":"Microtubule-associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma","volume":"166","author":"Soltani","year":"2005","journal-title":"Am J Pathol Jun"},{"key":"10.1016\/j.sder.2011.11.006_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000011989","article-title":"S100B protein detection in serum is a significant prognostic factor in metastatic melanoma","volume":"56","author":"Hauschild","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.sder.2011.11.006_bib18","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1535-7163.MCT-10-0901","article-title":"Melanoma prognosis: A REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies","volume":"10","author":"Schramm","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.sder.2011.11.006_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncponc0252","article-title":"REporting recommendations for tumor MARKer prognostic studies (REMARK)","volume":"2","author":"McShane","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.sder.2011.11.006_bib20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1096-9098(199903)70:3<150::AID-JSO2>3.0.CO;2-Z","article-title":"Prognostic evaluation of cutaneous malignant melanoma: A clinicopathologic and immunohistochemical study","volume":"70","author":"Niezabitowski","year":"1999","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.sder.2011.11.006_bib21","first-page":"271","article-title":"Combinations of apoptosis and cell-cycle control biomarkers predict the outcome of human melanoma","volume":"20","author":"Piras","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.sder.2011.11.006_bib22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jaad.2010.03.035","article-title":"Correlation between insulin-like growth factor binding protein-3 serum level and melanoma progression","volume":"64","author":"Panasiti","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.sder.2011.11.006_bib23","unstructured":"Rushing EC, Stine MJ, Hahn SJ, et al: Neuropilin-2: A novel biomarker for malignant melanoma? Hum Pathol (in press)"},{"key":"10.1016\/j.sder.2011.11.006_bib24","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.cca.2011.07.027","article-title":"Circulating cell-free DNA in plasma of melanoma patients: Qualitative and quantitative considerations","volume":"412","author":"Pinzani","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.sder.2011.11.006_bib25","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with Vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.11.006_bib26","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1001\/jama.2011.746","article-title":"KIT as a therapeutic target in metastatic melanoma","volume":"305","author":"Carvajal","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.sder.2011.11.006_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.11.006_bib28","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.sder.2011.11.006_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/jid.2009.334","article-title":"KIT as a therapeutic target in melanoma","volume":"130","author":"Garrido","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.sder.2011.11.006_bib30","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/jid.2011.58","article-title":"Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: Results of a United States case-control study","volume":"131","author":"Curiel-Lewandrowski","year":"2011","journal-title":"J Invest Dermatol"}],"container-title":["Seminars in Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1085562911001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scmsjournal.com\/wp-content\/uploads\/2016\/01\/SCMS_vol31_no1_Malignant_Melanoma.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T03:29:31Z","timestamp":1640834971000},"score":1,"resource":{"primary":{"URL":"http:\/\/scmsjournal.com\/article\/buy_now\/?id=141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1085562911001970"],"URL":"https:\/\/doi.org\/10.1016\/j.sder.2011.11.006","relation":{},"ISSN":["1085-5629"],"issn-type":[{"value":"1085-5629","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}